A tree at Terwilliger Boulevard and Condor Lane fell on an SUV, smashing the vehicle. The driver, who was headed to the Doernbecher Children's Hospital to visit their child, was able to safely exit the vehicle, and Portland Fire took them to them to Doernbecher.

OHSU is one of several organizations partnering with Adventures Without Limits to provide access to the outdoors for people who might not otherwise be able to participate in outdoor recreation, including those who face barriers due to their socioeconomic status, gender, ethnicity or age.

The Lund Report interviews Desiree McCue, D.N.P., M.B.A., RN, about the OHSU Department of Obstetrics and Gynecology's decision to “lease” the services of five fertility specialists to Spring Fertility under a physicians services agreement; the company opens a clinic in Northwest Portland on April 1, 2024.

Titas Banerjee, M.D., a hematology-oncology fellow in the OHSU Knight Cancer Institute, was included in the inaugural class of Bio Ascend’s “Academy of Next Wave of Investigators” at a networking reception during the ASH meeting. The clinical investigators are participating in a year-long opportunity to engage in live and virtual career development seminars with international thought leaders in the fields of chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

In an article about how soon flu symptoms appear after exposure and what those symptoms look like, Marcel Curlin, M.D., advises getting the flu vaccine and masking or isolating if exposed: “If I were in contact with someone in the community or elsewhere with a flu ... I would probably wear a mask all the time, and be very careful to wash my hands and not get too close to people.”

In an Oregon Capital Chronicle article about a lack of addiction treatment services in jails — despite the fact that many inmates have substance use disorder problems — Dan Hoover, M.D., discusses his recent study and says, “Incarceration could be a chance to be starting people on these evidence-based medicines, and we’re basically missing that chance.”

A novel stool test for colorectal cancer screening achieved a sensitivity of 94% for colorectal cancer screening. David Lieberman, M.D., says: “The test demonstrated high sensitivity and specificity across all age groups, with significant improvement in sensitivity for colorectal neoplasia when compared to a FIT [fecal immunochemical test]. The mt-sRNA test met its primary end points and is being considered for approval by the FDA.”

Arpita Gandhi, M.D., presents results from a Phase IB clinical trial studying stem cell therapy Orca-T, a type of blood cancer therapy that is made of donor stem and immune cells. The study found promising efficacy and safety outcomes for patients with intermediate to high-risk myelodysplastic syndrome. Gandhi says: “Orca-T demonstrated promising results in this high-risk MDS patient population, including high RFS, low incidence of GVHD and very high OS at one year.”

Arpita Gandhi, M.D., presents results from a Phase IB clinical trial studying stem cell therapy Orca-T, a type of blood cancer therapy that is made of donor stem and immune cells. The study found promising efficacy and safety outcomes for patients with intermediate to high-risk myelodysplastic syndrome. Gandhi says: “Orca-T demonstrated promising results in this high-risk MDS patient population, including high RFS, low incidence of GVHD and very high OS at one year."

Arpita Gandhi, M.D., presents results from a Phase IB clinical trial studying stem cell therapy Orca-T, a type of blood cancer therapy that is made of donor stem and immune cells. The study found promising efficacy and safety outcomes for patients with intermediate to high-risk myelodysplastic syndrome. Gandhi says: “Orca-T demonstrated promising results in this high-risk MDS patient population, including high RFS, low incidence of GVHD and very high OS at one year.”